Advanced Biomed Inc.
ADVB
$0.71
$0.074211.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 81.47% | -16.55% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 45.08% | 1.10% | |||
| Operating Income | -45.08% | -1.10% | |||
| Income Before Tax | -52.43% | -241.83% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -52.43% | -241.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -52.43% | -241.83% | |||
| EBIT | -45.08% | -1.10% | |||
| EBITDA | -60.44% | -2.13% | |||
| EPS Basic | -48.90% | -241.35% | |||
| Normalized Basic EPS | -48.59% | -242.17% | |||
| EPS Diluted | -48.90% | -241.35% | |||
| Normalized Diluted EPS | -48.59% | -242.17% | |||
| Average Basic Shares Outstanding | 2.40% | 0.00% | |||
| Average Diluted Shares Outstanding | 2.40% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||